Centre Publications

2016

Please click here for publications from the current year

Please click here for publications from other years

Author(s) Title Year Citation
Beale DJ, Jones OA, Karpe AV, Dayalan S, Oh DY, Kouremenos KA, Ahmed W and Palombo EA A review of analytical techniques and their application in disease diagnosis in breathomics and salivaomics research 2016 Int J Mol Sci 18(1). 
PubMed link
DOI:10.3390/ijms18010024
Barr IG and Wong FY Avian influenza: why the concern? 2016 Microbiology Australia November. 
Website link
DOI:10.1071/MA16055
Lau H and Hurt AC Assessment of the RNASound RNA sampling card for the preservation of influenza virus RNA 2016 Front Microbiol 7: 1736. 
PubMed link
DOI:10.3389/fmicb.2016.01736
Hurt AC, Su YC, Aban M, Peck H, Lau H, Baas C, Deng YM, Spirason N, Ellstrom P, Hernandez J, Olsen B, Barr IG, Vijaykrishna D and Gonzalez-Acuna D Evidence for the introduction, reassortment, and persistence of diverse influenza A viruses in Antarctica 2016 J Virol 90(21): 9674-9682. 
PubMed link
DOI:10.1128/JVI.01404-16
Jelley L, Levy A, Deng YM, Spirason N, Lang J, Buettner I, Druce J, Blyth C, Effler P, Smith D and Barr IG Influenza C infections in Western Australia and Victoria from 2008 to 2014 2016 Influenza Other Respir Viruses 10(6): 455-461. 
PubMed link
DOI:10.1111/irv.12402
Moss R, McCaw JM, Cheng AC, Hurt AC and McVernon J Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context 2016 BMC Infect Dis 16(1): 552. 
PubMed link
DOI:10.1186/s12879-016-1866-7
Komadina N, Quiñones-Parra SM, Kedzierska K, McCaw JM, Kelso A, Leder K and McVernon J High conservation level of CD8+ T cell immunogenic regions within an unusual H1N2 human influenza variant2016 J Med Virol 88(10): 1725-1732. 
PubMed link
DOI:10.1002/jmv.24516
Pennington K, Bareja C, Sullivan SG, Franklin LJ and Raupach J Influenza surveillance in Australia 2016 Commun Dis Intell Q Rep 40(3): E315-E316. 
PubMed link
Sullivan SG, Raupach J, Franklin LJ, Pennington K, Bareja C, de Kluyver R and and the National Influenza Surveillance Committee A brief overview of influenza surveillance systems in Australia, 2015 2016 Commun Dis Intell Q Rep 40(3): E351-E355. 
PubMed link
Fielding JE, Levy A, Chilver MB, Deng YM, Regan AK, Grant KA, Stocks NP and Sullivan SG Effectiveness of seasonal influenza vaccine in Australia, 2015: An epidemiological, antigenic and phylogenetic assessment 2016 Vaccine 34(41): 4905-4912. 
PubMed link
DOI:10.1016/j.vaccine.2016.08.067
McBride WJ, Abhayaratna WP, Barr I, Booy R, Carapetis J, Carson S, De Looze F, Ellis-Pegler R, Heron L, Karrasch J, Marshall H, McVernon J, Nolan T, Rawlinson W, Reid J, Richmond P, Shakib S, Basser RL, Hartel GF, Lai MH, Rockman S and Greenberg ME Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trial 2016 Vaccine 34(41): 4991-4997. 
PubMed link
DOI:10.1016/j.vaccine.2016.08.038
Sullivan SG, Cowling BJ and Greenland S Frailty and influenza vaccine effectiveness 2016 Vaccine 34(39): 4645-4646. 
PubMed link
DOI:10.1016/j.vaccine.2016.08.003
Gillespie L, Gerstenberg K, Ana-Sosa-Batiz F, Parsons MS, Farrukee R, Krabbe M, Spann K, Brooks AG, Londrigan SL and Reading PC DC-SIGN and L-SIGN are attachment factors that promote infection of target cells by human metapneumovirus in the presence or absence of cellular glycosaminoglycans 2016 J Virol 90(17): 7848-7863. 
PubMed link
DOI:10.1128/JVI.00537-16
Sullivan SG, Tchetgen Tchetgen EJ and Cowling BJ Theoretical basis of the test-negative study design for assessment of influenza vaccine effectiveness 2016 Am J Epidemiol 184(5): 345-353. 
PubMed link
DOI:10.1093/aje/kww064
Sullivan SG, Carville KS, Chilver M, Fielding JE, Grant KA, Kelly H, Levy A, Stocks NP, Tempone SS and Regan AK Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014 2016 Epidemiol Infect 144(11): 2317-2328. 
PubMed link
DOI:10.1017/S0950268816000819
Gordon DL, Sajkov D, Honda-Okubo Y, Wilks SH, Aban M, Barr IG and Petrovsky N Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax delta inulin adjuvant 2016 Vaccine 34(33): 3780-3786. 
PubMed link
DOI:10.1016/j.vaccine.2016.05.071
Job ER, Pizzolla A, Nebl T, Short KR, Deng YM, Carolan L, Laurie KL, Brooks AG and Reading PC Neutralizing inhibitors in the airways of naive ferrets do not play a major role in modulating the virulence of H3 subtype influenza A viruses 2016 Virology 494: 143-157. 
PubMed link
DOI:10.1016/j.virol.2016.01.024
Milne GJ, Halder N, Kelso JK, Barr IG, Moyes J, Kahn K, Twine R and Cohen C Trivalent and quadrivalent influenza vaccination effectiveness in Australia and South Africa: results from a modelling study 2016 Influenza Other Respir Viruses 10(4): 324-332. 
PubMed link
DOI:10.1111/irv.12367
Kristensen AB, Lay WN, Ana-Sosa-Batiz F, Vanderven HA, Madhavi V, Laurie KL, Carolan L, Wines BD, Hogarth M, Wheatley AK and Kent SJ Antibody responses with Fc-mediated functions after vaccination of HIV-Infected subjects with trivalent influenza vaccine 2016 J Virol 90(12): 5724-5734. 
PubMed link
DOI:10.1128/JVI.00285-16
Hurt AC, Besselaar TG, Daniels RS, Ermetal B, Fry A, Gubareva L, Huang W, Lackenby A, Lee RT, Lo J, Maurer-Stroh S, Nguyen HT, Pereyaslov D, Rebelo-de-Andrade H, Siqueira MM, Takashita E, Tashiro M, Tilmanis D, Wang D, Zhang W and Meijer A Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015 2016 Antiviral Res 132: 178-185. 
PubMed link
DOI:10.1016/j.antiviral.2016.06.001
Bond HS, Sullivan SG, Cowling BJ Regression approaches in the test-negative study design for assessment of influenza vaccine effectiveness 2016 Epidemiol Infect. 2016 Jun;144(8):1601-11 
PubMed link
doi: 10.1017/S095026881500309X
Dalziel AE, Peck HA, Hurt AC, Cooke J and Cassey P Proposed surveillance for Influenza A in feral pigs 2016 Ecohealth 13(2): 410-414. 
PubMed link
DOI:10.1007/s10393-016-1126-8
Hurt AC and Kelly H Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza 2016 Emerg Infect Dis 22(6): 949-955. 
PubMed link
DOI:10.3201/eid2206.151037
Vanderven HA, Ana-Sosa-Batiz F, Jegaskanda S, Rockman S, Laurie K, Barr I, Chen W, Wines B, Hogarth PM, Lambe T, Gilbert SC, Parsons MS and Kent SJ What lies beneath: antibody dependent natural killer cell activation by antibodies to internal influenza virus proteins 2016 EBioMedicine 8: 277-290. 
PubMed link
DOI:10.1016/j.ebiom.2016.04.029
Li C, Hatta M, Burke DF, Ping J, Zhang Y, Ozawa M, Taft AS, Das SC, Hanson AP, Song J, Imai M, Wilker PR, Watanabe T, Watanabe S, Ito M, Iwatsuki-Horimoto K, Russell CA, James SL, Skepner E, Maher EA, Neumann G, Klimov AI, Kelso A, McCauley J, Wang D, Shu Y, Odagiri T, Tashiro M, Xu X, Wentworth DE, Katz JM, Cox NJ, Smith DJ and Kawaoka Y Selection of antigenically advanced variants of seasonal influenza viruses 2016 Nat Microbiol 1(6): 16058. 
PubMed link
DOI:10.1038/nmicrobiol.2016.58
Ana-Sosa-Batiz F, Vanderven H, Jegaskanda S, Johnston A, Rockman S, Laurie K, Barr I, Reading P, Lichtfuss M and Kent SJ Influenza-Specific Antibody-Dependent Phagocytosis 2016 PLoS One 11(4): e0154461. 
PubMed link
DOI:10.1371/journal.pone.0154461
Leung VK, Cowling BJ, Feng S and Sullivan SG Concordance of interim and final estimates of influenza vaccine effectiveness: a systematic review 2016 Euro Surveill 21(16). 
PubMed link
DOI:10.2807/1560-7917.ES.2016.21.16.30202
Feng S, Cowling BJ and Sullivan SG Influenza vaccine effectiveness by test-negative design - Comparison of inpatient and outpatient settings 2016 Vaccine 34(14): 1672-1679. 
PubMed link
DOI:10.1016/j.vaccine.2016.02.039
FitzPatrick M, Royce SG, Langenbach S, McQualter J, Reading PC, Wijburg O, Anderson GP, Stewart A, Bourke J and Bozinovski S Neonatal pneumococcal colonisation caused by influenza A infection alters lung function in adult mice 2016 Sci Rep 6: 22751. 
PubMed link
DOI:10.1038/srep22751
Carolan LA, Rockman S, Borg K, Guarnaccia T, Reading P, Mosse J, Kelso A, Barr I and Laurie KL Characterization of the localized immune response in the respiratory tract of ferrets following infection with influenza A and B viruses 2016 J Virol 90(6): 2838-2848. 
PubMed link
DOI:10.1128/JVI.02797-15
Edenborough KM, Lowther S, Laurie K, Yamada M, Long F, Bingham J, Payne J, Harper J, Haining J, Arkinstall R, Gilbertson B, Middleton D and Brown LE Predicting disease severity and viral spread of H5N1 influenza virus in ferrets in the context of natural exposure routes 2016 J Virol 90(4): 1888-1897. 
PubMed link
DOI:10.1128/JVI.01878-15
Oh DY and Hurt AC Using the ferret as an animal model for investigating influenza antiviral effectiveness 2016 Front Microbiol 7: 80. 
PubMed link
DOI:10.3389/fmicb.2016.00080
Fielding JE, Regan AK, Dalton CB, Chilver MB and Sullivan SG How severe was the 2015 influenza season in Australia? 2016 Med J Aust 204(2): 60-61. 
PubMed link
Kotecha RS, Wadia UD, Jacoby P, Ryan AL, Blyth CC, Keil AD, Gottardo NG, Cole CH, Barr IG and Richmond PC Immunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer 2016 Cancer Med 5(2): 285-293. 
PubMed link
DOI:10.1002/cam4.596
Mifsud EJ, Tan AC, Reading PC and Jackson DC Mapping the pulmonary environment of animals protected from virulent H1N1 influenza infection using the TLR-2 agonist Pam(2)Cys 2016 Immunol Cell Biol 94(2): 169-176. 
PubMed link
DOI:10.1038/icb.2015.81
Nguyen ML, Hatton L, Li J, Olshansky M, Kelso A, Russ BE and Turner SJ Dynamic regulation of permissive histone modifications and GATA3 binding underpin acquisition of granzyme A expression by virus-specific CD8(+) T cells 2016 Eur J Immunol 46(2): 307-318. 
PubMed link
DOI:10.1002/eji.201545875
Ren B, McKinstry WJ, Pham T, Newman J, Layton DS, Bean AG, Chen Z, Laurie KL, Borg K, Barr IG and Adams TE Structural and functional characterisation of ferret interleukin-2 2016 Dev Comp Immunol 55: 32-38. 
PubMed link
DOI:10.1016/j.dci.2015.10.007
Barr IG, Vijaykrishna D and Sullivan SG Differential age susceptibility to influenza B/Victoria lineage viruses in the 2015 Australian influenza season 2016 Euro Surveill 21(4). 
PubMed link
DOI:10.2807/1560-7917.ES.2016.21.4.30118
Eichelberger MC, Couzens L, Gao Y, Levine M, Katz J, Wagner R, Thompson CI, Hoschler K, Laurie K, Bai T, Engelhardt OG and Wood J Comparability of neuraminidase inhibition antibody titers measured by enzyme-linked lectin assay (ELLA) for the analysis of influenza vaccine immunogenicity 2016 Vaccine 34(4): 458-465. 
PubMed link
DOI:10.1016/j.vaccine.2015.12.022
Gillespie L, Roosendahl P, Ng WC, Brooks AG, Reading PC and Londrigan SL Endocytic function is critical for influenza A virus infection via DC-SIGN and L-SIGN 2016 Sci Rep 6: 19428. 
PubMed link
DOI:10.1038/srep19428
Tang FS, Van Ly D, Spann K, Reading PC, Burgess JK, Hartl D, Baines KJ and Oliver BG Differential neutrophil activation in viral infections: Enhanced TLR-7/8-mediated CXCL8 release in asthma 2016 Respirology 21(1): 172-179. 
PubMed link
DOI:10.1111/resp.12657
Ng WC, Londrigan SL, Nasr N, Cunningham AL, Turville S, Brooks AG and Reading PC The C-type lectin langerin functions as a receptor for attachment and infectious entry of influenza A virus 2016 J Virol 90(1): 206-221. 
PubMed link
DOI:10.1128/JVI.01447-15

Top of Page